Sandimmun neoral, a new oral formulation of cyclosporin A with improved pharmacokinetic characteristics: safety and tolerability in renal transplant patients.
Taesch
S
S
Department of Clinical Research, Sandoz Pharma Ltd, Basle, Switzerland.
Niese
D
D
Mueller
E A
EA
D000284:Administration, Oral; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000008:administration & dosage / Q000493:pharmacokinetics* / Q000627:therapeutic use / Q000633:toxicity*; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology; D013997:Time Factors
D016572:Cyclosporine; D003404:Creatinine